Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis

Author： Uhlenhake Elizabeth E   Feldman Steven R  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.10, Iss.7, 2010-07, pp. : 1105-1112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The efficacy and safety of golimumab in the treatment of arthritis

By Fleischmann Roy  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1131-1143

Informa Healthcare

Access to resources Recommend Favorite

Etanercept in the treatment of rheumatoid arthritis

By Hunt Laura   Emery Paul  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 10, 2013-10 ,pp. : 1441-1450

Informa Healthcare

Access to resources Recommend Favorite

Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety

By Beck Michael  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 2, 2009-02 ,pp. : 255-261

Informa Healthcare

Access to resources Recommend Favorite

Plasma transforming growth factor β1 as a biomarker of psoriasis activity and treatment efficacy

By Flisiak Iwona   Pore˛bski Piotr   Flisiak Robert   Chodynicka Bożena  

Biomarkers, Vol. 8, Iss. 5, 2003-10 ,pp. : 437-443

Informa Healthcare

Access to resources Recommend Favorite

Psoriasis and its treatment with adalimumab

By Iaconi Ala   Feldman Steven R   Balkrishnan Rajesh  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 1, 2010-01 ,pp. : 133-152

Informa Healthcare

Access to resources Recommend Favorite